(re)producing the Israeli (European) body: Zionism, Anti-Black Racism and the Depo-Provera Affair

This article examines the Depo-Provera Affair—where Israeli doctors administered the contraceptive Depo-Provera to newly immigrated Ethiopian Jewish women—to argue that the Israeli settler colonial project depends on these forms of gendered anti-Black violence, through the management of Black African bodies. In 2013, then Israeli Deputy Health Minister Yaakov Litzman admitted that they had administered Depo-Provera to Ethiopian immigrant women without their consent, after reproductive and civil rights activists in Israel called for an investigation after a drop in the birthrate among Ethiopian women: close to 50 per cent within the previous decade. The demarcation of Blackness as a political tool necessary to advance Israeli modernity and the situating of Black bodies as antithetical to the state of Israel are not contradictory but rather illuminate Israel’s deployment of anti-Blackness through the racial and reproductive violence necessary to become part of the superior, European West.

Relationship of Contraceptive Use Depo Provera with The Side Effects On Acceptance in Nulle Health Center

Contraception is an effort to prevent the onsany of pregnancy that is temporary and can be permanent. One of the contraceptive methods that is in demand by the public is the hormonal contraceptive method, namely the injectable contraceptive Depo Provera. Hormonal contraceptive methods are considered one method with high effectiveness, but on the other hand hormonal contraceptives especially those containing progesterone have some side effects such as menstrual cycle disorders, spotting, increased blood pressure and weight gain. This study aims to find out the relationship between the use of injectable contraceptive Depo Provera with the occurrence of side effects on the acceptance in Nulle publick health center South Central Timor Regency in 2020. This type of research is quantitative research using a cross sectional study approach. The sample in this study was 95 acceptances spread across 8 villages that became the working area of Nulle Health Center. The data analysis used is univariate analysis and bivariate analysis using Chi-square test. The characteristics of the majority of respondents aged 21-30 years and 31-40 years were 42.9%, not working 55.6%, high school education 54.0% and parity 1-2 people as much as 49.2%. The results of the data analysis showed there is a relationship between the use of injectable contraceptive Depo Provera with side effects in the form of menstrual cycle disorders (ρ-value = 0.004), spotting (ρ-value = 0.006) and increase in weight (ρ-value = 0.010) while unrelated side effects are an increase in blood pressure (ρ-value = 0.423). Advice for health officials especially in the field of maternal and child health and family planning to increase the frequency of counseling/information to acceptors, especially injectable contraceptive acceptors Depo Provera regarding the side effects of contraceptive use and other factors that can influence the onsling of such side effects by utilizing health promotion media, so that the acceptor can have a good information/understanding of the contraceptive used.

Investigation of the Possible Effects of Injectable and Skin Patch Contraceptives on Selected Haemostatic and Haematologic Parameters in Women Attending Primary Healthcare Centre in Eleme, Rivers State

The was a case control and comparative study aimed at investigating the possible effects of injectable and skin patch contraceptives on selected haematologic and haemostatic parameters in women attending primary healthcare centre at Eleme, Rivers State The study population consists of seventy-five (75) apparently healthy, non-pregnant, non- smoking women, aged between 25 and 45years; (31 women on DEPO-PROVERA contraceptive, 14 women on Implanon, and 30 apparently healthy non-contraceptive users as control group). Fibrinogen, antithrombin, tissue plasminogen activator was analysed with reagents prepared by Elabscience, Wuhan, China, using an ELISA machine (STAT FAX-2100). Prothrombin time and activated partial thromboplastin time was done manually with reagents prepared by Quimica Clinica Aplicada S.A, Spain. Haematologic parameters were analysed using SYSMEX KX-21-N auto analyser. Graph-pad Prism 5.0 was used in analysing all data, p < 0.05 was considered statistically significant. For haemostatic parameters, results showed that there was statistically significant increase in mean values of antithrombin (38.48 ± 17.48/ml versus 21.02 ± 15.54ng/ml, p=0.0011) and tissue plasminogen activator (1.34 ± 1.35ng/ml versus 0.28 ± 0.46ng/ml, p=0.0047) in women using the two types of contraceptive, while activated partial thromboplastin time (28.11± 2.37s versus 29.87 ± 2.77s, p=0.0205) was statistically decreased in women on the investigated contraceptives, other haemostatic parameters were not statistically significant. For haematological parameters, the results showed that there was statistically significant increase in mean values of packed cell volume 38.13 ± 2.28% versus 36.21 ± 3.07% (p=0.0126), haemoglobin 12.35 ± 0.79g/dL versus 11.56 ± 0.99g/dL (p=0.0028), white blood cells 6.17 ± 1.22 x109/L versus 5.26 ± 1.18 x109/L (p=0.0143) in women using injectable (DEPO-PROVERA) and skin patch (IMPLANON) contraceptive, other parameters showed no statistically significance. Based on duration of use of contraceptive, there was no statistically significant difference (p>0.05) in women using skin patch; while for injectable, platelet count was high in those who had used it for more than a year. Comparing values obtained from using injectable and skin patch, there was no statistical significant difference in all the parameters. Using analysis of variance to compare values based on parity, there was no statistical significant difference. Conclusively, increase in antithrombin and tissue plasminogen activator, and a decrease in activated partial thromboplastin time in women using IMPLANON (skin patch) and DEPO-PROVERA (injectable) are the haemostatic changes that occurs while using contraceptives and these changes may likely predispose them to bleeding, therefore adequate monitoring of the blood haemostatic processes while taking these contraceptives is critical in order not to expose users to haemorrhage.

Side effects and discontinuation rate of depot medroxyprogesterone acetate in a tertiary hospital, southern Nigeria

Background: Depot medroxyprogesterone acetate (DMPA) also known as depo provera is a highly effective, safe and long-lasting reversible contraceptive with side effects that may cause discontinuation amongst acceptors. Objective was to determine the prevalence rate, side effects, discontinuation rate and indications for discontinuation of DMPA at Rivers State University Teaching Hospital (RSUTH), Port Harcourt.Methods: This was a retrospective study of 874 clients attending family planning clinic at the RSUTH from 1st January, 2015 to 31st December, 2019. Their records were retrieved from the clinic and reviewed. Data was extracted, coded and analyzed using the statistical package for social sciences (SPSS) IBM version 25.0 (Armonk, NY).Results: One hundred and one clients accepted DMPA out of 874 acceptors of contraceptives within the study period giving a prevalence rate of 11.6%. The modal age group was 25-29 years accounting for 31 (30.7%). Age range was 19-47 years and the modal parity was para 2. Majority of the clients had formal education, 100 (99%), married, 94 (93.1%) and multipara 61 (60.4%). The discontinuation rate was 32.7% and the commonest reasons for discontinuation were secondary amenorrhoea and irregular vaginal bleeding with each contributing 24.2%.Conclusions: The prevalence and discontinuation rates of Depo provera were low. Secondary amenorrhoea and irregular vaginal bleeding were the commonest side effects and reasons for discontinuation.

HUBUNGAN PENGETAHUAN IBU TENTANG KONTRASEPSI SUNTIK DEPO PROVERA DENGAN KEPATUHAN KUNJUNGAN ULANG DI POLINDES KUALA II KABUPATEN KUBU RAYA TAHUN 2015

HUBUNGAN PENGETAHUAN IBU TENTANG KONTRASEPSI SUNTIK DEPO PROVERA DENGAN KEPATUHAN KUNJUNGAN ULANG DI POLINDES KUALA II KABUPATEN KUBU RAYA TAHUN 2015Denny Pebrianti1, Yuliana2Akademi Kebidanan Panca Bhakti PontianakEmail korespondensi: [email protected] Kontrasepsi depo provera kontrasepsi suntik yang memiliki efektifitas yang tinggi, apabila dilakukan secara teratur sesuai jadwal yang ditentukan. Studi menunjukkan bahwa 60 sampai dengan 78 % wanita menjadi hamil atau gagal menggunakan kontrasepsi yang disebabkan karena ketidakpatuhan kunjungan ulang suntikan. Berdasarkan data yang diperoleh dari Polindes Kuala II tahun 2016, jumlah akseptor yang menggunakan kontrasepsi suntik sebanyak 869 akseptor, dari jumlah tersebut ada 3 akseptor yang mengalami kegagalan yang disebabkan ketidakpatuhan kunjungan ulang suntikan. Tujuan penelitian ini untuk mengetahui hubungan pengetahuan ibu tentang kontrasepsi suntik Depo provera dengan kepatuhan kunjungan ulang di Polindes Kuala II Kabupaten Kubu Raya Tahun 2016. Jenis penelitian yang dipakai adalah penelitian deskriptif korelasi dengan pendekatan survey. Dalam penelitian ini menggunakan teknik sampling Nonprobability Sampling. Besar sampel dalam penelitian ini yaitu 51 responden yang memenuhi kriteria inklusi. Uji analisis yang digunakan adalah Kendall Tau-b dengan menggunakan program statistical product service solution. Hasil penelitian menjelaskan bahwa akseptor yang pengetahuannya baik dengan kepatuhan tinggi kunjungan ulang suntikan depo provera sebesar 31%, akseptor dengan pengetahuan cukup dan kepatuhan sedang terhadap kunjungan ulang suntikan depo provera ada sebesar 27%, akseptor berpengetahuan kurang dengan kepatuhan rendah terhadap kunjungan ulang suntikan depo provera sebesar 14%. Hasil P value=0,000 <α = 0,05, maka H0 ditolak dan Ha diterima dengan nilai koefisien korelasi sebesar 0,677 berarti ada hubungan yang kuat pengetahuan ibu tentang kontrasepsi suntik depo provera dengan kepatuhan kunjungan ulang di Polindes Kuala II Kabupaten Kubu Raya tahun 2016. Kesimpulan dari penelitian ini adalah ada hubungan yang kuat pengetahuan ibu tentang kontrasepsi suntik depo provera dengan kepatuhan kunjungan ulang di Polindes Kuala II Kabupaten Kubu Raya tahun 2016. Oleh karena itu diharapkan kepada petugas kesehatan untuk dapat terus memberikan pemahaman tentang pentingnya melakukan kunjungan ulang sesuai jadwal yang telah ditentukan serta meningkatkan pengetahuan akseptor tentang kontrasepsi suntik depo provera.Kata Kunci: Pengetahuan, Depo Provera, Kepatuhan, Kunjungan Ulang

HUBUNGAN PENGGUNAAN KB SUNTIK DEPO PROVERA 3 BULAN TERHADAP KADAR Hb PADA WUS WANITA USIA SUBUR DI BPM (BIDAN PRAKTEK MANDIRI) NUNI NURAENI KELURAHAN PADASUKA CIOMAS KABUPATEN BOGOR

Family Planning is an acronym for Family Planning which was formed by the government to reduce the number of people using contraception, but some contraceptives have side effects namely bleeding, headache, nausea, menstrual disorders, weakness/fatigue, and vaginal discharge. This study was an observational analytic study with a cross-sectional design. Samples were all users of 3 months Depo Provera Injecting KB injection at BPM Nuni Nuraeni, Padasuka Ciomas, Bogor Regency in 2018. Statistical tests used chi-square. The results of univariate analysis showed WUS using Depo Provera injections 3 months 49 (65.3%) and WUS who did not use Depo Provera injections 3 months 26 (34.7%), WUS who used 3 months Depo Provera injectable KB obtained that Hb levels were normal 43 (57.3%) and whereas WUS who used KB injections Depo Provera 3 months found that Hb levels were not normal 32 (42.7%). In the Bivariate analysis, based on the results of the Chi-Square Statistical Test with a significance limit α = 0.05 and 95% CI obtained ρ value = 0.26 α> 0.05 (Prevalence Rate = 3,300). This shows that there is no relationship between the use of 3 months Depo Provera injecting contraception to Hb levels in WUS at BPM Nuni Nuraeni. Thus the hypothesis which states that there is a relationship between the use of 3 months Depo Provera injecting contraception with Hb levels in WUS is rejected. From the results of the study it can be concluded that there is no relationship between the use of a 3-month injection of Depo Provera injections with Hb levels in WUS at BPM Nuni Nuraeni, Padasuka Ciomas, Bogor Regency.